Results 171 to 180 of about 484,964 (356)

Prescription drug use in breastfeeding mothers and infant exposure: A register‐based cohort study

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Abstract Aims Breast milk is the optimal infant nutrition; however, many infants may be exposed to prescription drugs if used by their mothers during breastfeeding. The aim of this study was to evaluate the prevalence and patterns of prescription drug use among breastfeeding mothers and to assess the availability of relative infant dose information for
Ditte Resendal Gotfredsen   +5 more
wiley   +1 more source

Working effectively with long-distance mentors,

open access: yesInternational Journal of Women's Dermatology, 2020
Ellen J. Kim, MD
doaj   +1 more source

Mild psoriasis as a suitable model for proof‐of‐mechanism in a phase 1B setting: Results from a double‐blind placebo‐controlled trial with guselkumab

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aims Early clinical development of novel psoriasis therapies is hampered by a decreasing number of moderate‐to‐severe psoriasis patients eligible for participation in trials since efficacious treatments, such as biologics, have become widely available.
Jannik Rousel   +11 more
wiley   +1 more source

Methotrexate‐induced melanonychia

open access: yes
Arthritis &Rheumatology, Accepted Article.
Yoshinori Taniguchi, Hirotaka Yamamoto
wiley   +1 more source

Innovative transdermal drug delivery systems: Benefits, challenges, and emerging application

open access: yesBMEMat, EarlyView.
The graphical abstract illustrates the diverse nanostructures employed in transdermal drug delivery systems, highlighting their unique mechanisms to penetrate the intricate layers of skin. It provides a detailed representation of the skin's complex anatomy, emphasizing the challenges posed by its barrier properties.
Syed Waqas Ali Shah   +9 more
wiley   +1 more source

Rapid regression of multiple melanocytic nevi in an individual with history of melanoma with the CDKN2A mutation

open access: yesJAAD Case Reports, 2023
Nor Fazil Jaber, MD   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy